ArticleFrontiers in immunology2026

Modulating CD38 enzymatic activity during antibody-based immunotherapy in multiple myeloma: a basic science perspective.

Alberto L Horenstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.